Other News To Note
Friday, September 20, 2013
• Argen-x BV, of Breda, the Netherlands, said it attained a milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Dublin-based Shire plc, triggering an undisclosed payment from Shire.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.